| Items | Drug Registration information |
|---|---|
| ID | 295 |
| No | 295 |
| Brand Name | CLOXACAP 500 |
| Ingredients | CLOXACILLIN SODIUM 500 MG |
| Dosage Form | CAPSULE |
| Primary Packaging | BLISTERPACK |
| Storage | |
| Shelf Life | 3 YEARS |
| Pack Size | BOX OF 10 X 10'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | INFECTION CAUSED BY PENICILLINASE-PRODUCING STAPHYLOCOCCI, RESPIRATORY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTION, DISSEMINATED INFECTION CAUSED BY PNEUMOCOCCI, GROUP A BETA-HEMOLYTIC STREPTOCOCCI AND PENICILLIN G-RESISTANT AND PENICILLIN G-SENSITIVE STAPHYLOCCI |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | ORANGE OPAQUE AND BLACK OPAQUE CAPSULE WITH "HD" PRINTED ON ONE END AND "CX500" ON THE OTHER END OF THE CAPSULE, CAPSULE SIZE 0, OFF WHITE POWDER |
| Note | |
| License Owner | BMS PHARMA SOLE CO.,LTD |
| Manufacturer | HOVID BHD |
| Country | MALAYSIA |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 04 I 4909/20 |
| FDD Registration Date | 07/06/2023 |
| Expiry Date | 06/06/2026 |